Global Non-Animal Softgel Capsules Market Size, Share, Trends and Forecast 2022-2030

Description

Non-animal Softgel Capsules is a kind of Softgels, a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
Non-animal Softgel Capsules are all-natural, GMO free, plant-based shell, free from animal derivatives, gluten, and modified sugars. Nowadays, Non-animal Softgel Capsules can be divided into several kinds such as Plant Polysaccharides (Pullulan), Starches, and Hydroxyl Propyl Methyl Celluloses. Non-animal Softgel Capsules possess the benefits of suited for Halal or Kosher certification; Pure, clear and elegant appearance with no taste or odor; Ideal for improving the bioavailability of oil soluble ingredients; Easy to swallow, safe, non-carcinogenic and tamper evident, etc.

Industry Insights

Due to the COVID-19 pandemic, the global Non-Animal Softgel Capsules market size is estimated to be worth US$ 553 million in 2021 and is forecast to a readjusted size of US$ 904.8 million by 2028 with a CAGR of 7.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Non-Animal Softgel Capsules market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Non-Animal Softgel Capsules landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Catalent, Procaps Laboratorios, Aenova, Bahrain Pharma, Robinson Pharma, etc. are the key vendors in the global vegetarian softgel capsules market. The top 5 took up more than 70% of the global market. Catalent, Procaps Laboratorios, Aenova, etc. which have leading technology and market position, are well-known vendors around the world.

Americas is the largest region of vegetarian softgel capsules in the world, which takes up about 47% of the global revenue market, while Europe and the Asia Pacific were about 23%, 20% respectively.

Vegetarian softgel capsules are mainly classified into the following types: plant polysaccharides and starch. Plant polysaccharides is the most widely used type which takes up about 75% of the total sales.

This product also has a wide range of applications, such as health supplements, pharmaceuticals, etc. And health supplements sector was the most widely used area which accounts for over 75% of the global total, the application in pharmaceutical focuses on OTC products.

This report focuses on Non-Animal Softgel Capsules volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Non-Animal Softgel Capsules market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Non-Animal Softgel Capsules market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Plant Polysaccharides Softgel Capsules

Starch Softgel Capsules

Segment by Application

Health Supplements

Pharmaceutical

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Catalent

Procaps Laboratorios

EuroCaps

Best Formulations

Aenova

Captek

Sirio

Bahrain Pharma

Robinson Pharma

Aland

Fuji Capsule

Sunsho Pharmaceutical

Erkang

TABLE OF CONTENT

1 Non-Animal Softgel Capsules Market Overview
1.1 Product Overview and Scope of Non-Animal Softgel Capsules

1.2 Non-Animal Softgel Capsules Segment by Type

1.2.1 Global Non-Animal Softgel Capsules Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Plant Polysaccharides Softgel Capsules

1.2.3 Starch Softgel Capsules

1.3 Non-Animal Softgel Capsules Segment by Application

1.3.1 Global Non-Animal Softgel Capsules Sales Comparison by Application: (2022-2028)

1.3.2 Health Supplements

1.3.3 Pharmaceutical

1.3.4 Others

1.4 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts

1.4.1 Global Non-Animal Softgel Capsules Revenue 2017-2028

1.4.2 Global Non-Animal Softgel Capsules Sales 2017-2028

1.4.3 Non-Animal Softgel Capsules Market Size by Region: 2017 Versus 2021 Versus 2028

2 Non-Animal Softgel Capsules Market Competition by Manufacturers

2.1 Global Non-Animal Softgel Capsules Sales Market Share by Manufacturers (2017-2022)

2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Non-Animal Softgel Capsules Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Non-Animal Softgel Capsules Manufacturing Sites, Area Served, Product Type

2.5 Non-Animal Softgel Capsules Market Competitive Situation and Trends

2.5.1 Non-Animal Softgel Capsules Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Non-Animal Softgel Capsules Players Market Share by Revenue

2.5.3 Global Non-Animal Softgel Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-Animal Softgel Capsules Retrospective Market Scenario by Region

3.1 Global Non-Animal Softgel Capsules Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Non-Animal Softgel Capsules Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Non-Animal Softgel Capsules Market Facts & Figures by Country

3.3.1 North America Non-Animal Softgel Capsules Sales by Country

3.3.2 North America Non-Animal Softgel Capsules Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Non-Animal Softgel Capsules Market Facts & Figures by Country

3.4.1 Europe Non-Animal Softgel Capsules Sales by Country

3.4.2 Europe Non-Animal Softgel Capsules Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Non-Animal Softgel Capsules Market Facts & Figures by Region

3.5.1 Asia Pacific Non-Animal Softgel Capsules Sales by Region

3.5.2 Asia Pacific Non-Animal Softgel Capsules Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Non-Animal Softgel Capsules Market Facts & Figures by Country

3.6.1 Latin America Non-Animal Softgel Capsules Sales by Country

3.6.2 Latin America Non-Animal Softgel Capsules Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Non-Animal Softgel Capsules Market Facts & Figures by Country

3.7.1 Middle East and Africa Non-Animal Softgel Capsules Sales by Country

3.7.2 Middle East and Africa Non-Animal Softgel Capsules Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Non-Animal Softgel Capsules Historic Market Analysis by Type

4.1 Global Non-Animal Softgel Capsules Sales Market Share by Type (2017-2022)

4.2 Global Non-Animal Softgel Capsules Revenue Market Share by Type (2017-2022)

4.3 Global Non-Animal Softgel Capsules Price by Type (2017-2022)

5 Global Non-Animal Softgel Capsules Historic Market Analysis by Application

5.1 Global Non-Animal Softgel Capsules Sales Market Share by Application (2017-2022)

5.2 Global Non-Animal Softgel Capsules Revenue Market Share by Application (2017-2022)

5.3 Global Non-Animal Softgel Capsules Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Catalent

6.1.1 Catalent Corporation Information

6.1.2 Catalent Description and Business Overview

6.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Catalent Non-Animal Softgel Capsules Product Portfolio

6.1.5 Catalent Recent Developments/Updates

6.2 Procaps Laboratorios

6.2.1 Procaps Laboratorios Corporation Information

6.2.2 Procaps Laboratorios Description and Business Overview

6.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio

6.2.5 Procaps Laboratorios Recent Developments/Updates

6.3 EuroCaps

6.3.1 EuroCaps Corporation Information

6.3.2 EuroCaps Description and Business Overview

6.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.3.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio

6.3.5 EuroCaps Recent Developments/Updates

6.4 Best Formulations

6.4.1 Best Formulations Corporation Information

6.4.2 Best Formulations Description and Business Overview

6.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Best Formulations Non-Animal Softgel Capsules Product Portfolio

6.4.5 Best Formulations Recent Developments/Updates

6.5 Aenova

6.5.1 Aenova Corporation Information

6.5.2 Aenova Description and Business Overview

6.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Aenova Non-Animal Softgel Capsules Product Portfolio

6.5.5 Aenova Recent Developments/Updates

6.6 Captek

6.6.1 Captek Corporation Information

6.6.2 Captek Description and Business Overview

6.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Captek Non-Animal Softgel Capsules Product Portfolio

6.6.5 Captek Recent Developments/Updates

6.7 Sirio

6.6.1 Sirio Corporation Information

6.6.2 Sirio Description and Business Overview

6.6.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sirio Non-Animal Softgel Capsules Product Portfolio

6.7.5 Sirio Recent Developments/Updates

6.8 Bahrain Pharma

6.8.1 Bahrain Pharma Corporation Information

6.8.2 Bahrain Pharma Description and Business Overview

6.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio

6.8.5 Bahrain Pharma Recent Developments/Updates

6.9 Robinson Pharma

6.9.1 Robinson Pharma Corporation Information

6.9.2 Robinson Pharma Description and Business Overview

6.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio

6.9.5 Robinson Pharma Recent Developments/Updates

6.10 Aland

6.10.1 Aland Corporation Information

6.10.2 Aland Description and Business Overview

6.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Aland Non-Animal Softgel Capsules Product Portfolio

6.10.5 Aland Recent Developments/Updates

6.11 Fuji Capsule

6.11.1 Fuji Capsule Corporation Information

6.11.2 Fuji Capsule Non-Animal Softgel Capsules Description and Business Overview

6.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio

6.11.5 Fuji Capsule Recent Developments/Updates

6.12 Sunsho Pharmaceutical

6.12.1 Sunsho Pharmaceutical Corporation Information

6.12.2 Sunsho Pharmaceutical Non-Animal Softgel Capsules Description and Business Overview

6.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio

6.12.5 Sunsho Pharmaceutical Recent Developments/Updates

6.13 Erkang

6.13.1 Erkang Corporation Information

6.13.2 Erkang Non-Animal Softgel Capsules Description and Business Overview

6.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Erkang Non-Animal Softgel Capsules Product Portfolio

6.13.5 Erkang Recent Developments/Updates

7 Non-Animal Softgel Capsules Manufacturing Cost Analysis

7.1 Non-Animal Softgel Capsules Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Non-Animal Softgel Capsules

7.4 Non-Animal Softgel Capsules Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Non-Animal Softgel Capsules Distributors List

8.3 Non-Animal Softgel Capsules Customers

9 Non-Animal Softgel Capsules Market Dynamics

9.1 Non-Animal Softgel Capsules Industry Trends

9.2 Non-Animal Softgel Capsules Market Drivers

9.3 Non-Animal Softgel Capsules Market Challenges

9.4 Non-Animal Softgel Capsules Market Restraints

10 Global Market Forecast

10.1 Non-Animal Softgel Capsules Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Type (2023-2028)

10.2 Non-Animal Softgel Capsules Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Application (2023-2028)

10.3 Non-Animal Softgel Capsules Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Non-Animal Softgel Capsules by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Non-Animal Softgel Capsules by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample